Multidisciplinary Colorectal Cancer Clinic
Colorectal Cancer Care The Multidisciplinary Colorectal Cancer Clinic at the University of Michigan Comprehensive Cancer Center is the leading colorectal cancer clinic in Michigan and one of the top programs nationally. To provide comprehensive care to patients with colon or rectal cancers, we integrate treatment options with the latest research allowing us to offer your patient the opportunity to have access to the most promising therapies. The clinic has been named a Blue Distinction Center for Complex and Rare Cancers by the Blue Cross and Blue Shield Association. That means we offer a comprehensive inpatient and outpatient cancer care program, delivered by a multidisciplinary team with subspecialty training and distinguished clinical expertise in treating complex and rare subtypes of cancer. We are committed to providing excellent care to all patients, no matter the complexity of their needs. Our multidisciplinary team includes cancer specialists in gastroenterology, medical oncology, surgery, diagnostic radiology, pathology and molecular pathology, radiation oncology and genetics. Many of these cancer experts take part in the weekly tumor board. Our treatment approach is based on the fact that a person is more than their disease. We recognize that many factors impact treatment outcomes and work in partnership with patients and their families to optimize the variables that we can. Support is provided through nursing, social work, nutrition services, spiritual counseling and psychiatric services when needed.
Meet the Team Arden Morris, MD Surgical Director Associate Professor Surgery
John Krauss, MD Medical Director Assistant Professor Hematology & Oncology
Alfred Chang, MD Professor, Surgery
Grace Chen, MD Assistant Professor Medical Oncology
Mary Feng, MD Assistant Professor Radiation Oncology
Karin Hardiman, MD Assistant Professor Surgery
Samantha Hendren, MD Associate Professor Surgery
James Knol, MD Associate Professor Surgery
Theodore Lawrence, MD, PhD Isadore Lampe Professor and Chair Radiation Oncology
Hari Nathan, MD, PhD Assistant Professor Surgery
Scott Regenbogen, MD Assistant Professor Surgery
Kim Turgeon, MD Associate Professor Internal Medicine
Christine Veenstra, MD Clinical Lecturer Hematology & Oncology
Theodore Welling, MD Assistant Professor Surgery
Elena Stoffel, MD Assistant Professor Internal Medicine
After Referral Patients in the Multidisciplinary Colorectal Cancer Clinic receive a comprehensive evaluation coordinated within a single clinic and single visit. A clinical nurse coordinator and program intake coordinator work together to gather records and schedule any additional screenings that may be needed for your patient. Patients are scheduled for their appointment within one to two weeks of referral. The appointment consists of a review of the medical record and diagnostic studies, obtaining a history from the patient and performing a physical examination. Patients also meet with each cancer specialist who will be involved in their treatment plan, giving patients the chance to review treatment options, ask questions and receive answers and outline a timeline for therapy. The treatment plan may include surgery, chemotherapy, radiation therapy or a combination. Our staff of highly trained surgeons, medical oncologists, radiation oncologists, advance practice nurses and physician assistants communicate frequently with each other and the rest of the multidisciplinary team to ensure that patient needs are quickly identified and addressed.
When Family History is a Concern The Multidisciplinary Colorectal Cancer Clinic also sees patients who do not have a diagnosis of colon or rectal cancer, but whose family has a history with this disease. Up to ten percent of colon cancers are due to single-gene inherited conditions. After consultation with a genetics expert, patients with a family history may be offered testing. Counseling includes strategies for lowering risk and recommendations for cancer screening.
Research and Innovation We are part of the U-M Comprehensive Cancer Center’s Gastrointestinal Oncology Specialized Program of Research Excellence (SPORE). This makes us just as collaborative with our research as we are in our clinical program. By involving more than 40 researchers from 18 departments we have made significant strides in researching gastrointestinal cancers. Our goal has been the identification of biologic, genetic and/or molecular processes that give rise to the development of gastrointestinal cancers. We offer clinical trials for patients who have not responded to standard therapies. We also invite our patients to provide biospecimens to further our understanding of molecular targeted strategies for the treatment of colorectal cancer. Patients may also elect to participate in studies which examine how the diagnosis of cancer and/or its treatment impacts their quality of life. Areas under current investigation include distress and sexual relationships.
U-M Comprehensive Cancer Center Colorectal Cancer Patients FY 2014
449 New Patients
9
%
RadiationOncology
11
%
Genetic Counseling
59% Medical
65% Surgical
We are happy to participate in care of the patient in whatever capacity desired by the referring physician and patient. Our interaction can be as brief as a visit offering a second opinion or as involved as performing surgery, rendering neoadjuvant and adjuvant therapy, and providing ongoing cancer surveillance. To make a referral to the Multidisciplinary Colorectal Cancer Clinic at the University of Michigan Comprehensive Cancer Center, or for a consult, call M-LINE at 800-962-3555.
CONTACT US For Referrals: 800-962-3555 Fax: 734-232-9365 U-M Comprehensive Cancer Center Colorectal Cancer Clinic 1500 E. Medical Center Dr., Floor B1 Ann Arbor, MI 48109 mcancer.org/colorectal-colon-cancer/clinic
University of Michigan Comprehensive Cancer Center Max S. Wicha, M.D., Director; Marcy B. Waldinger, MHSA, Chief Administrative Officer Executive Officers of the University of Michigan Health System
The Regents of the University of Michigan
Michael M.E. Johns, M.D., Interim Executive Vice President for Medical Affairs; James O. Woolliscroft, M.D., Dean, U-M Medical School; T. Anthony Denton, J.D., MHA, Acting Chief Executive Officer, U-M Hospitals and Health Centers; Kathleen Potempa, Ph.D., Dean, School of Nursing.
Mark J. Bernstein, Julia Donovan Darlow, Laurence B. Deitch, Shauna Ryder Diggs, Denise Ilitch, Andrea Fischer Newman, Andrew C. Richner, Katherine E. White, Mark S. Schlissel (ex officio).
The University of Michigan, is a non-discriminatory affirmative action employer. Š 2014 The Regents of the University of Michigan